This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atrialfibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%. Additional advantages include providing electrophysiology lab personnel with a lead-free working environment and avoiding radiation exposure for both patients and physicians.
Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrialfibrillation ablation, Musat et al. Early recurrence of atrial tachyarrhythmia (ERAT) is commonly seen following catheter ablation of AF, with reported incidences of up to 61% in the first three months.
It highlights the confluence of two major cardiovascular epidemics, atrialfibrillation and heart failure, with preserved ejection fraction. In these conditions, advances in electrophysiology and heart failure physiology are intertwined and are integrated in this review.
This week, the Cleveland Clinic enrolled the first patient in the AVANT GUARD trial, overseen by Dr. Oussama Wazni, vice chair of cardiovascular medicine and section head, Cardiac Electrophysiology and Pacing, Cleveland Clinic, who is also serving as the lead investigator of the trial. Circulation.
Methods PARALELL is a first-in-human multicenter study evaluating safety and effectiveness of a novel PFCA catheter and system in patients with persistent atrialfibrillation (PsAF) using the combination of pulmonary vein (PVI) and posterior wall (PWI) isolation. Results Sixty-six patients were ablated at six sites.
The most productive journals were Europace and the Journal of Interventional Cardiac Electrophysiology. The institution with the largest output was The Icahn School of Medicine at Mount Sinai. Prolific authors were identified, underscoring significant international collaborations.
Methods PFA was performed in patients with paroxysmal atrialfibrillation using novel hexaspline PFA catheter, and serum bilirubin, hemoglobin and renal function were measured at baseline and the next day post ablation.
Introduction Catheter ablation is an effective and safe strategy for treating atrialfibrillation patients. Method Patient baseline characteristics and electrophysiological parameters were examined to identify the predictors of atrialfibrillation recurrence following catheter ablation.
Additional rhythm-control strategies are frequently continued after index ablation for atrialfibrillation (AFib), according to a study published Feb. 12 in JACC: Clinical Electrophysiology.
Background Sacubitril/valsartan (SacVal) has been shown to improve the prognosis of heart failure; however, whether SacVal reduces the occurrence of atrialfibrillation (AF) in heart failure has not yet been elucidated. SacVal attenuated the increased heterogeneity of CV at short pacing cycle length in atria, whereas Val could not.
ABSTRACT Introduction In atrialfibrillation (AF) ablation procedures, the CARTO VIZIGO Bidirectional Guiding Sheath has previously shown promising results in reducing fluoroscopy times without compromising clinical effectiveness or safety compared with non-steerable sheaths.
I appreciated the simplicity of the system and the insight it provides during complex redo AFib cases," said Dr. Wilber Su , Director of Cardiac Electrophysiology at Banner-University Medical Center and Associate Professor of Medicine at the University of Arizona.
An atrialfibrillation (AF) model was created with isoproterenol and acetylcholine. In the presence of pinacidil induced arrhythmogenicity, neither SGLT2 inhibitor had a significant impact on cardiac electrophysiology. Conclusion In this model, empagliflozin and dapagliflozin demonstrated opposite antiarrhythmic properties.
Definitely atrialfibrillation. Probably WPW but is very slow for atrial fib withWPW. So this looks like WPW with Atrialfibrillation. What is unusual is that the rate is not REALLY fast, as you expect when there is atrial fib with an accessory pathway. My response: "Definitely not polymorphic VT.
he utility of left atrial appendage occlusion (LAAO) as a therapy for stroke prevention in patients with nonvalvular atrialfibrillation (AFib) is the focus of a State-of-the-Art Review published Jan. 8 in JACC: Clinical Electrophysiology.
Objective Catheter ablation of atrialfibrillation effectively reduces symptomatic burden. We investigated if patients with atrialfibrillation who undergo catheter ablation have lower risk for all-cause mortality or stroke than patients who are managed medically.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:The strongest genetic risk factors for atrialfibrillation (AF) are DNA variants on chromosome 4q25 near the transcription factor genePITX2.
Patients who present with persistent atrialfibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrialfibrillation (AFib).
These luminaries in the field of cardiac electrophysiology shared their vast knowledge and clinical acumen, guiding the participants through the intricacies of atrialfibrillation (AFib) management and empowering them to push the boundaries of their skills. Dr. Emin Evren Özcan and Assoc. Oguzhan Ekrem Turan.
Isolation line placed at the pulmonary vein antrum (PVA) area is superior to ostium level in atrialfibrillation (AF) control. However, less is known about the electrophysiological characteristics of PVA.
Epicardial Marshall bundle (MB) are frequently utilized in left atrial tachycardias (LATs) post atrialfibrillation (AF) ablation with pulmonary vein isolation and substrate modification.
The differential of wide complex irregularly irregular includes: polymorphic VT, atrialfibrillation with WPW, atrialfibrillation with other aberrancy. Thus, the patients rhythm is atrialfibrillation with WPW. With that in mind, how would you proceed with treatment?
The incidence of atrialfibrillation (AF) is significantly higher in patients with pacemakers than in the general population, which could be due to patient characteristics and the diagnostic tool of the pacemaker in detecting atrial high-rate episodes and subclinical AF, but also to the pacemaker itself providing AF-promoting conditions.
She also has a hx of paroxysmal atrialfibrillation and is on oral anticoagulant treatment. The patient is female in her 80s with a medical hx of previous MI with PCI and stent placement. She had a single chamber ICD/Pacemaker implanted several years prior due to ventricular tachycardia.
PT is an 82-year-old man who presents with persistent, mildly symptomatic atrialfibrillation (AF) of approximately 4-5 months' duration. He also has New York Heart Association (NYHA) class II heart failure with reduced ejection fraction and left ventricular ejection fraction (LVEF) 40%.
Backgroundwide antral pulmonary vein isolation (PVI) is effective for treating paroxysmal atrialfibrillation (PAF), although time-demanding. Procedural data and electrophysiology (EP) laboratory times were systematically collected and analyzed.
Atrialfibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.
Abstract Background and Aims Atrialfibrillation is the most prevalent cardiac arrhythmia, and catheter ablation (CA) has emerged as a viable treatment option for selected patients. However, its safety profile in liver cirrhosis (LC) populations remains underexplored.
Abstract Introduction Some previous studies have reported that a first-step ethanol infusion into the vein of Marshall (EIVOM) with touch-up radiofrequency (RF) ablation can facilitate mitral isthmus (MI) block and improves the ablation outcomes in persistent atrialfibrillation (PeAF) patients.
“Atrialfibrillation begets atrialfibrillation” describes the experimental observation, that artificial maintenance of atrialfibrillation (AF) leads to a marked shortening of atrial effective refractory period, and increase in inducibility and stability of AF, which is completely reversible within one week of sinus rhythm (1).
While the application of artificial intelligence (AI) in cardiovascular medicine is rising especially for wearable, smart and implantable devices, its use in interventional electrophysiology during an atrialfibrillation (AF) catheter ablation procedure is still emerging.
These luminaries in the field of cardiac electrophysiology shared their vast knowledge and clinical acumen, guiding the participants through the intricacies of atrialfibrillation (AFib) management and empowering them to push the boundaries of their skills. Dr. Emin Evren Özcan and Assoc. Oguzhan Ekrem Turan.
The first procedures, performed by leading physicians Saibal Kar , MD, FACC, FSCAI, (Program Director, Cardiovascular Disease Fellowship, Los Robles Health System , California, HCA Healthcare National Physician Director, Interventional Cardiology) and Devi Nair , MD, FACC, FHRS, (Director, Cardiac Electrophysiology Division, St.
Abstract Introduction Atrialfibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant. This arrhythmia was successfully terminated with radiofrequency ablation.
Age is an independent risk factor for the development of atrialfibrillation (AF). While AF arises in old age, the combined effects of widespread structural, electrophysiological and autonomic remodeling make it difficult to discern the exact mechanisms of arrhythmia generation.
Atrialfibrillation (AF) is the most common heart arrhythmia and considered to be a progressive chronic disease associated with an increased morbidity and mortality. Recent data suggests a link between inflammation, oxidative stress and AF, although the underlying mechanisms are not fully understood.
Whenever it is this fast, you need to be very careful to ascertain whether it is irregular ( as in atrialfibrillation with rapid ventricular respsonse ) or regular ( as in VT ). This is not because it is polymorphic VT; it is because it is WPW with atrialfibrillation. Atrialfibrillation/flutter in pre-excitation.
intermittent) atrialfibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. intermittent) atrialfibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. "The
The PRO portion of the currently featured PRO/CON debate between Dr. Brian Olshansky and Dr. John Mandrola presents a significant conundrum within the fields of electrophysiology and geriatric cardiology.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content